Docetaxel in combination with either cisplatin or gemcitabine in unresectable non-small cell lung carcinoma: a randomized phase II study by the Japan Lung Cancer Cooperative Clinical Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples